MDA
MDA (sassafras) is a psychedelic amphetamine closely related to MDMA, producing similar euphoria and empathogenic effects but with stronger psychedelic and stimulant properties and greater neurotoxicity risk. It is a Schedule I controlled substance in the US, and illicit supply is subject to fentanyl and misrepresentation risk.
Overview
MDA (3,4-methylenedioxyamphetamine) is a psychoactive drug of the amphetamine and phenethylamine families, closely related to MDMA. It is both an entactogen (producing emotional openness and empathy) and a psychedelic stimulant, and is sometimes sold as or mistaken for MDMA. It is also a metabolite of MDMA, meaning the body converts some MDMA into MDA.
Source: DEA; peer-reviewed literature (NIH/PMC); Wikipedia (CC-BY-SA)
Chemistry & mechanism of action
MDA increases release of serotonin, dopamine, and norepinephrine and blocks their reuptake, raising their levels in the brain, which produces its stimulant and empathogenic effects. It also has direct activity at serotonin receptors, giving it more pronounced psychedelic effects than MDMA. This heavy serotonin release underlies both the acute effects and the concern about serotonergic neurotoxicity.
Source: peer-reviewed literature (NIH/PMC); DEA
Effects
Effects overlap with MDMA — euphoria, emotional warmth, empathy, energy, and heightened senses — but MDA is generally described as more stimulating and more psychedelic, with more visual effects and a longer duration. Physical effects include raised heart rate and blood pressure, jaw clenching, dilated pupils, and reduced appetite, followed by a comedown with low mood and fatigue.
Source: peer-reviewed literature (NIH/PMC); DEA
Risks & harms
MDA shares MDMA's acute dangers and is thought to carry greater neurotoxic risk. Heavy serotonin and dopamine release strains the cardiovascular system (raised heart rate and blood pressure) and can cause dangerous overheating (hyperthermia), especially with physical exertion in hot environments, and water imbalance — both too little and, dangerously, too much water intake leading to hyponatremia. Combining MDA with other serotonergic drugs — SSRIs, MAOIs, other stimulants, or other empathogens — raises the risk of serotonin syndrome, a potentially fatal reaction with high fever, rigidity, agitation, and rapid heart rate. Longer, more stimulating experiences increase the strain. A critical contamination hazard applies to the illicit supply: substances sold as MDA or MDMA are frequently adulterated or entirely different, and pills and powders in this market have been found to contain illicitly manufactured fentanyl, which can cause fatal respiratory depression. There is no way to confirm identity or dose by eye. Anyone with a very high temperature, seizures, chest pain, collapse, or a severe psychiatric crisis needs emergency care — call 911, and Poison Control at 1-800-222-1222 can advise. This page has not yet been medically reviewed.
Source: DEA; SAMHSA; peer-reviewed literature (NIH/PMC)
Legal status (US)
In the United States, MDA is a Schedule I controlled substance, the federal category for substances treated as having no accepted medical use and a high potential for abuse. It has long been federally controlled, applies nationwide with severe penalties for manufacture, distribution, and possession, and is controlled internationally under the UN Convention on Psychotropic Substances. Follow local law; consult DEA resources for specifics. This page has not yet been medically reviewed.
Source: DEA; US federal law; UN Convention on Psychotropic Substances
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
After MDMA, overheating and over-hydration are both dangerous: cool down, and sip to thirst rather than gulping water (forcing plain water can drop your blood sodium dangerously).
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 1614PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- 1-(1,3-benzodioxol-5-yl)propan-2-aminePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C10H13NO2PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CC(CC1=CC2=C(C=C1)OCO2)NPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- NGBBVGZWCFBOGO-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- sass, sally, Tenamfetamine, 3,4-methylenedioxyamphetamine, Methylenedioxyamphetamine, Tenamfetaminum, Love, methylene dioxyamphetamine, Tenanfetamina, 3,4 Methylenedioxyamphetamine, 3,4-Methylenedioxy-amphetamine, MDA (pharmaceutical)PubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review
- Route
- Unknown — pending review
- Shape
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Color
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Imprint
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Score
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown — pending review
Dosage
Pending medical reviewer
